The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Acerta Pharma
Consulting or Advisory Role - Global Blood Therapeutics
Acalabrutinib (Acala) versus idelalisib plus rituximab (IdR) or bendamustine plus rituximab (BR) in relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL): ASCEND final results.
 
Paolo Ghia
Honoraria - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen Oncology; Juno Therapeutics; MEI Pharma; Sunesis Pharmaceuticals
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; ArQule; BeiGene; Dynamo Therapeutics; Gilead Sciences; Janssen; Juno Therapeutics; MEI Pharma; Sunesis Pharmaceuticals
Research Funding - Abbvie; Gilead Sciences; Janssen Oncology; Novartis; Sunesis Pharmaceuticals
 
Andrzej Pluta
Honoraria - Celgene; Novartis; SERVIER; Takeda
Research Funding - Acerta Pharma; BeiGene; IQvia; Janssen-Cilag; Kartos Therapeutics; Pharmacyclics; Roche; Takeda
Travel, Accommodations, Expenses - Celgene
 
Malgorzata Wach
No Relationships to Disclose
 
Daniel Lysak
Consulting or Advisory Role - Abbvie; Janssen-Cilag; Novartis; Roche
 
Tomas Kozak
Consulting or Advisory Role - Abbvie; Amgen; Gilead Sciences; Novartis
Travel, Accommodations, Expenses - Abbvie; Takeda
 
Martin Simkovic
Honoraria - Abbvie/Genentech; Janssen-Cilag
Consulting or Advisory Role - Abbvie
Speakers' Bureau - Abbvie; Abbvie; Janssen-Cilag
Travel, Accommodations, Expenses - Abbvie; Abbvie; Gilead Sciences; Janssen-Cilag; Janssen-Cilag
 
Polina Kaplan
No Relationships to Disclose
 
Iryna Kraychok
Consulting or Advisory Role - Janssen Oncology; Takeda
Research Funding - Abbvie; Acerta Pharma; Bayer; Debiopharm Group; Janssen Oncology; Karyopharm Therapeutics; MSD Oncology
Expert Testimony - Janssen Oncology; Takeda
Travel, Accommodations, Expenses - Abbvie; MSD Oncology; Roche; Takeda
 
Arpad Illes
Consulting or Advisory Role - Janssen; Novartis; Pfizer; Roche; Takeda
Travel, Accommodations, Expenses - Janssen; Novartis; Pfizer; Roche
 
Javier De La Serna
Consulting or Advisory Role - Abbvie; AstraZeneca; Janssen
Speakers' Bureau - Abbvie; Janssen
Travel, Accommodations, Expenses - Abbvie; AstraZeneca
 
Sean Dolan
No Relationships to Disclose
 
Philip Campbell
Consulting or Advisory Role - Amgen; AstraZeneca; CSL Behring; Janssen; Novartis; Roche
 
Gerardo Musuraca
Consulting or Advisory Role - AstraZeneca; Debiopharm Group; Gilead Sciences; Janssen
Research Funding - Acerta Pharma; AstraZeneca; Bayer; BeiGene; Celerion; Debiopharm Group; Epizyme; Janssen; MEI Pharma; Merck; MorphoSys; Roche; SERVIER; TG Therapeutics
 
Abraham Jacob
Stock and Other Ownership Interests - AstraZeneca; GlaxoSmithKline; Horizon Discovery; Midlands Haematology Services; Oxford Biomedica
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Eric Joseph Avery
Consulting or Advisory Role - AstraZeneca
Research Funding - Lilly
Travel, Accommodations, Expenses - AstraZeneca
 
Jae Hoon Lee
No Relationships to Disclose
 
Denise Wang
No Relationships to Disclose
 
Priti Patel
Employment - AstraZeneca
Stock and Other Ownership Interests - AstraZeneca
 
Cheng Seok Quah
Employment - Acerta Pharma
Stock and Other Ownership Interests - AstraZeneca; Roche/Genentech
Travel, Accommodations, Expenses - Acerta Pharma/AstraZeneca
 
Wojciech Jurczak
Consulting or Advisory Role - AstraZeneca; Debiopharm Group; Epizyme; Epizyme; Gilead Sciences; Janssen-Cilag; Roche
Research Funding - Acerta Pharma; Affimed Therapeutics; Bayer; BeiGene; Celltrion; Debiopharm Group; Epizyme; Gilead Sciences; Incyte; Janssen-Cilag; MEI Pharma; Merck; Morphosys; Roche; Sandoz-Novartis; Takeda; TG Therapeutics; TG Therapeutics